: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription

Articles published in PLoS One
Retrieve available abstracts of 394 articles:
HTML format

Single Articles

January 2025

CARRASCO S, Liphaus BL, Peixoto TV, Lima TM, et al
Early neutrophil activation and NETs release in the pristane-induced lupus mice model.
PLoS One. 2025;20:e0306943.
PubMed Abstract available

SIEBALD F, Grittner U, Otto C, Bereuter C, et al
Ultrasound pupillometry for the detection of a relative afferent pupillary defect (RAPD): Systematic evaluation in patients with optic neuritis and comparison with infrared video pupillometry.
PLoS One. 2025;20:e0315712.
PubMed Abstract available

XU Y, Wang Z, Jia T, Liang S, et al
Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology.
PLoS One. 2025;20:e0316481.
PubMed Abstract available

KATZ A, Shulkin A, Fortier MA, Yardley JE, et al
Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis.
PLoS One. 2025;20:e0313051.
PubMed Abstract available

RAO GA, Shoaibi A, Makadia R, Hardin J, et al
CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
PLoS One. 2025;20:e0310634.
PubMed Abstract available

January 2024

XUE H, Zeng L, He H, Xu D, et al
Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
PLoS One. 2024;19:e0291685.
PubMed Abstract available

EKMAN L, Dahlin LB, Andersson GS, Lindholm E, et al
Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies.
PLoS One. 2024;19:e0296661.
PubMed Abstract available

MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
PLoS One. 2024;19:e0290879.
PubMed Abstract available

DASGUPTA SK, Gollamudi J, Rivera S, Poche RA, et al
beta2-glycoprotein I promotes the clearance of circulating mitochondria.
PLoS One. 2024;19:e0293304.
PubMed Abstract available

TOLF A, Gauffin H, Burman J, Landtblom AM, et al
Experiences of being treated with autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: A qualitative interview study.
PLoS One. 2024;19:e0297573.
PubMed Abstract available

YANG H, Chen Z, Huang J, Li S, et al
AWD-stacking: An enhanced ensemble learning model for predicting glucose levels.
PLoS One. 2024;19:e0291594.
PubMed Abstract available

DADVAR A, Jameie M, Azizmohammad Looha M, Parsaei M, et al
Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial.
PLoS One. 2024;19:e0297235.
PubMed Abstract available

JAKA S, Singh S, Vashist S, Pokhrel S, et al
Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study.
PLoS One. 2024;19:e0296870.
PubMed Abstract available

MITTAL R, McKenna K, Keith G, Lemos JRN, et al
A systematic review of the association of Type I diabetes with sensorineural hearing loss.
PLoS One. 2024;19:e0298457.
PubMed Abstract available

SHEMIRANI F, Pingel WR, Titcomb TJ, Salari-Moghaddam A, et al
The effect of dietary interventions on inflammatory biomarkers among people with multiple sclerosis: A protocol for systematic review and meta-analysis of randomized controlled trials.
PLoS One. 2024;19:e0297510.
PubMed Abstract available

JEONG HS, Chun BC
COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
PLoS One. 2024;19:e0297902.
PubMed Abstract available

LIU X, Xue J, Li T, Wu Q, et al
Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.
PLoS One. 2024;19:e0298269.
PubMed Abstract available

SMUDJA M, Milenkovic T, Minakovic I, Zdravkovic V, et al
Self-care activities in pediatric patients with type 1 diabetes mellitus.
PLoS One. 2024;19:e0300055.
PubMed Abstract available

TRAN TT, Nguyen TN, Dauvilliers Y, Liblau R, et al
Absence of specific autoantibodies in patients with narcolepsy type 1 as indicated by an unbiased random peptide-displayed phage screening.
PLoS One. 2024;19:e0297625.
PubMed Abstract available

JOZEF M, Locatelli I, Brecl Jakob G, Savsek L, et al
Psychometric evaluation of the 5-item Medication Adherence Report Scale questionnaire in persons with multiple sclerosis.
PLoS One. 2024;19:e0294116.
PubMed Abstract available

LIU P, Luo J, Zhao L, Fu Q, et al
Causal relationship between several autoimmune diseases and renal malignancies: A two-sample mendelian randomization study.
PLoS One. 2024;19:e0297861.
PubMed Abstract available

FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper.
PLoS One. 2024;19:e0298796.
PubMed Abstract available

LIU Z, Fan T, Mo X, Kan J, et al
Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
PLoS One. 2024;19:e0298271.
PubMed Abstract available

CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human and mouse oligodendrocytes: Exploring their role in neuroinflammation and multiple sclerosis.
PLoS One. 2024;19:e0283060.
PubMed Abstract available

LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
PLoS One. 2024;19:e0300914.
PubMed Abstract available

BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
PLoS One. 2024;19:e0300708.
PubMed Abstract available

IMRAISH A, Abu Thiab T, Alsalem M, Dahbour S, et al
The neuroprotective effect of human primary astrocytes in multiple sclerosis: In vitro model.
PLoS One. 2024;19:e0300203.
PubMed Abstract available

ESIASON DC, Ciesinski N, Nurse CN, Erler W, et al
The psychological burden of NMOSD - a mixed method study of patients and caregivers.
PLoS One. 2024;19:e0300777.
PubMed Abstract available

KAMPAITE A, Gustafsson R, York EN, Foley P, et al
Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
PLoS One. 2024;19:e0299634.
PubMed Abstract available

MA J, Xing J, Zhang Y, Liu G, et al
Efficacy and safety of biologic agents for IgA nephropathy: A protocol for systematic review and meta-analysis.
PLoS One. 2024;19:e0298732.
PubMed Abstract available

JANSSENS N, Van Wilder L, Van Hecke A, Van Hoorenbeeck K, et al
COCCOS study: Developing a transition program for adolescents with chronic conditions using Experience-Based Co-Design. A study protocol.
PLoS One. 2024;19:e0298571.
PubMed Abstract available

MEDINA-RAMIREZ SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, et al
Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis.
PLoS One. 2024;19:e0296998.
PubMed Abstract available

YAGHOOBPOOR S, Fathi M, Vakili K, Sayehmiri F, et al
Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
PLoS One. 2024;19:e0297091.
PubMed Abstract available

LOMER NB, Asalemi KA, Saberi A, Sarlak K, et al
Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
PLoS One. 2024;19:e0300415.
PubMed Abstract available

LI H, Huntington S, Gross C, Wang SY, et al
Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease.
PLoS One. 2024;19:e0300789.
PubMed Abstract available

DE RIDDER F, Braspenning R, Ordonez JS, Klarenbeek G, et al
Early feasibility study with an implantable near-infrared spectroscopy sensor for glucose, ketones, lactate and ethanol.
PLoS One. 2024;19:e0301041.
PubMed Abstract available

SCAGNELLATO L, Cozzi G, Prosepe I, Lorenzin M, et al
Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience.
PLoS One. 2024;19:e0298679.
PubMed Abstract available

SVENSSON AK, Dahlin LB, Rydberg M, Perez R, et al
Surgery for carpal tunnel syndrome in patients with and without diabetes-Is there a difference in the frequency of surgical procedures?
PLoS One. 2024;19:e0302219.
PubMed Abstract available

ZHOU K, Zhou J, Zhou L, Xue J, et al
Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
PLoS One. 2024;19:e0302100.
PubMed Abstract available

UEDA H, Joh K, Ueda Y, Marumoto H, et al
Accelerated involution of germinal center in palatine tonsils in IgA nephropathy.
PLoS One. 2024;19:e0301853.
PubMed Abstract available

LEE YH, Song GG
Platelet-to-lymphocyte ratio as a biomarker of systemic inflammation in systemic lupus erythematosus: A meta-analysis and systematic review.
PLoS One. 2024;19:e0303665.
PubMed Abstract available

ZHAI Y, Tian H, Zhang W, Sun S, et al
Genome-wide analysis of long noncoding RNAs as cis-acting regulators of transcription factor-encoding genes in IgA nephropathy.
PLoS One. 2024;19:e0304301.
PubMed Abstract available

CREMER T, Hoelen H, van de Weijer ML, Janssen GM, et al
Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2.
PLoS One. 2024;19:e0287877.
PubMed Abstract available

COBB J, Rawson J, Gonzalez N, Orr C, et al
Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
PLoS One. 2024;19:e0303863.
PubMed Abstract available

REBALKA IA, Noguchi KS, Bulyovsky KR, Badour MI, et al
Targeting skeletal muscle health with exercise in people with type 1 diabetes: A protocol for HOMET1D, a prospective observational trial with matched controls.
PLoS One. 2024;19:e0303448.
PubMed Abstract available

JEONG C, Baek H, Bae J, Hwang N, et al
Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
PLoS One. 2024;19:e0300678.
PubMed Abstract available

HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
PLoS One. 2024;19:e0300298.
PubMed Abstract available

DUAN P, Tian S
Mendelian randomization analyses reveal no genetic causal effects of major adipokines on systemic lupus erythematosus.
PLoS One. 2024;19:e0301699.
PubMed Abstract available

EKELUND C, Dereke J, Nilsson C, Landin-Olsson M, et al
Are soluble E-selectin, ICAM-1, and VCAM-1 potential predictors for the development of diabetic retinopathy in young adults, 15-34 years of age? A Swedish prospective cohort study.
PLoS One. 2024;19:e0304173.
PubMed Abstract available

BALDASSO BD, Raza SZ, Islam SS, Burry IB, et al
Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue.
PLoS One. 2024;19:e0303211.
PubMed Abstract available

BAXTER F, Baillie N, Dover A, Stimson RH, et al
A cross-sectional questionnaire study: Impaired awareness of hypoglycaemia remains prevalent in adults with type 1 diabetes and is associated with the risk of severe hypoglycaemia.
PLoS One. 2024;19:e0297601.
PubMed Abstract available

STEFANOVIC M, Jovanovic I, Zivkovic M, Stankovic A, et al
Pathway analysis of peripheral blood CD8+ T cell transcriptome shows differential regulation of sphingolipid signaling in multiple sclerosis and glioblastoma.
PLoS One. 2024;19:e0305042.
PubMed Abstract available

ALMUTAIRI FF
The feasibility of point shear wave elastography (pSWE) in the assessment of pancreas stiffness in diabetic patients and healthy volunteers.
PLoS One. 2024;19:e0303098.
PubMed Abstract available

CHI G, Pei J, Li X
Inflammatory bowel disease and risk of autoimmune hepatitis: A univariable and multivariable Mendelian randomization study.
PLoS One. 2024;19:e0305220.
PubMed Abstract available

SERATA EL, Noonan EJ, Petersen KH
Barriers to USMLE Step-1 accommodations: Students with Type 1 Diabetes.
PLoS One. 2024;19:e0304784.
PubMed Abstract available

HE L, He W
Clinicopathologic features and outcomes of bilateral lacrimal gland lesions.
PLoS One. 2024;19:e0305717.
PubMed Abstract available

GEBREMESKEL GG, Haile TG, Gebrewahd GT, Hailay A, et al
Effectiveness of non-pharmacological therapies for chronic pain in people with autoimmune diseases in Africa: A protocol for a systematic review and meta-analysis.
PLoS One. 2024;19:e0306564.
PubMed Abstract available

LI Z, Jia B, Guo Z, Zhang K, et al
Therapeutic potential of salidroside in type I diabetic erectile dysfunction: Attenuation of oxidative stress and apoptosis via the Nrf2/HO-1 pathway.
PLoS One. 2024;19:e0306926.
PubMed Abstract available

PIKULIN S, Yehezkel I, Moskovitch R
Enhanced blood glucose levels prediction with a smartwatch.
PLoS One. 2024;19:e0307136.
PubMed Abstract available

SUMIMOTO H, Noda S, Koide H, Douke Y, et al
Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors.
PLoS One. 2024;19:e0306995.
PubMed Abstract available

CAMPANIONI S, Veiga C, Prieto-Gonzalez JM, Gonzalez-Novoa JA, et al
Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors.
PLoS One. 2024;19:e0306999.
PubMed Abstract available

YAMADA K, Tanabe A, Hashimoto M, Ohsugi M, et al
A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
PLoS One. 2024;19:e0308076.
PubMed Abstract available

WANG YY, Ying HM, Tian F, Qian XL, et al
Three months use of Hybrid Closed Loop Systems improves glycated hemoglobin levels in adolescents and children with type 1 diabetes: A meta-analysis.
PLoS One. 2024;19:e0308202.
PubMed Abstract available

KIM N, Kim S, Choi JR, Park Y, et al
Evaluation of autoimmune liver disease antibodies in hepatitis patients.
PLoS One. 2024;19:e0307285.
PubMed Abstract available

LI B, Zhang L, Li Q, Zhang J, et al
Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.
PLoS One. 2024;19:e0308815.
PubMed Abstract available

LEE MJ, Verma R, Hamilton BE, Pettersson D, et al
The utility of orbital imaging in the evaluation of orbital disease.
PLoS One. 2024;19:e0308528.
PubMed Abstract available

CHAIPRASERT A, Han P, Laomettachit T, Ruengjitchatchawalya M, et al
Network analysis retrieving bioactive compounds from Spirulina (Arthrospira platensis) and their targets related to systemic lupus erythematosus.
PLoS One. 2024;19:e0309303.
PubMed Abstract available

KAKUCS Z, Illes Z, Hayden Z, Berki T, et al
Osteopontin predicts late-time salience network-related functional connectivity in multiple sclerosis.
PLoS One. 2024;19:e0309563.
PubMed Abstract available

WEISE S, Du Y, Heidemann C, Baumert J, et al
Diabetes self-management education programs: Results from a nationwide population-based study on characteristics of participants, rating of programs and reasons for non-participation.
PLoS One. 2024;19:e0310338.
PubMed Abstract available

D'ALESSANDRO M, Cameli P, Cotton CV, Lamb JA, et al
Panel of serum biomarkers for differential diagnosis of idiopathic interstitial lung disease and interstitial lung disease-secondary to systemic autoimmune rheumatic disease.
PLoS One. 2024;19:e0311357.
PubMed Abstract available

CAMBOULIVE L, Grandhomme F, Martin Silva N, Khoy K, et al
Clinical impact of ceruloplasmin levels at ANCA-associated vasculitis diagnosis.
PLoS One. 2024;19:e0311678.
PubMed Abstract available

MAGEAU A, Geradin C, Sallah K, Papo T, et al
Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: A matched cohort study.
PLoS One. 2024;19:e0309316.
PubMed Abstract available

BUIANOVA A, Yukina M, Cheranev V, Suchalko O, et al
Trio-based exome sequencing and high-resolution HLA typing in families of patients with autoimmune adrenal insufficiency and autoimmune polyglandular syndrome.
PLoS One. 2024;19:e0312335.
PubMed Abstract available

SOKRATOUS D, Charalambous CC, Zamba-Papanicolaou E, Michailidou K, et al
A 12-week in-phase bilateral upper limb exercise protocol promoted neuroplastic and clinical changes in people with relapsing remitting multiple sclerosis: A registered report randomized single-case concurrent multiple baseline study.
PLoS One. 2024;19:e0299611.
PubMed Abstract available

SABOYA-GALINDO P, Mejia-Salgado G, Cifuentes-Gonzalez C, Rodriguez-Rodriguez CA, et al
Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.
PLoS One. 2024;19:e0307455.
PubMed Abstract available

KOVACEVIC S, Zdravkovic V, Blagojevic J, Djordjevic S, et al
Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.
PLoS One. 2024;19:e0312489.
PubMed Abstract available

GIRAUD E, Fiette L, Melanitou E
Type 1 diabetes and parasite infection: An exploratory study in NOD mice.
PLoS One. 2024;19:e0308868.
PubMed Abstract available

TISELL A, Soderberg K, Link Y, Lundberg P, et al
Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.
PLoS One. 2024;19:e0309547.
PubMed Abstract available

FABER W, Stillebroer AB
Addressing bladder and bowel challenges in dutch multiple sclerosis patients: Symptom prevalence and patient referral pathways.
PLoS One. 2024;19:e0310691.
PubMed Abstract available

NAFARI A, Vaheb S, Afshari-Safavi A, Ravankhah Z, et al
Cancer and mortality risks among people with multiple sclerosis: A population-based study in Isfahan, Iran.
PLoS One. 2024;19:e0312707.
PubMed Abstract available

LI Y, Kong D, Ding Y, Wang J, et al
The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis.
PLoS One. 2024;19:e0308546.
PubMed Abstract available

IAQUINTO S, Ineichen BV, Salmen A, Kuhle J, et al
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approach.
PLoS One. 2024;19:e0312486.
PubMed Abstract available

DE LA CRUZ A, Garces M, Larios E, Madera-Salcedo IK, et al
Immune complex deposition promotes NK cell accumulation in the kidney.
PLoS One. 2024;19:e0312141.
PubMed Abstract available

MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
PLoS One. 2024;19:e0311117.
PubMed Abstract available

RIVERA-FRANCO N, Lopez-Alvarez D, Castillo A, Aristizabal E, et al
Genomic variability in Zika virus in GBS cases in Colombia.
PLoS One. 2024;19:e0313545.
PubMed Abstract available

NAJMI EA, Mirzaasgari Z, Motamed MR, Aslani A, et al
Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.
PLoS One. 2024;19:e0314031.
PubMed Abstract available

SALEEM O, Iqbal J
Blood-glucose regulator design for diabetics based on LQIR-driven Sliding-Mode-Controller with self-adaptive reaching law.
PLoS One. 2024;19:e0314479.
PubMed Abstract available

ZURRER WE, Cannon AE, Ewing E, Bruschweiler D, et al
STEED: A data mining tool for automated extraction of experimental parameters and risk of bias items from in vivo publications.
PLoS One. 2024;19:e0311358.
PubMed Abstract available

MIRMOSAYYEB O, Yazdan Panah M, Mokary Y, Mohammadi M, et al
Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis.
PLoS One. 2024;19:e0312421.
PubMed Abstract available

CHEIBCHALARD T, Leelahavanichkul A, Chatthanathon P, Klankeo P, et al
Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
PLoS One. 2024;19:e0314662.
PubMed Abstract available

TSUNODA R, Kume K, Kagawa R, Sanuki M, et al
Machine-learning-based identification of patients with IgA nephropathy using a computerized medical billing database.
PLoS One. 2024;19:e0312915.
PubMed Abstract available

RASOULI S, Dakkali MS, Ghazvini A, Azarbad R, et al
Predictive model for converting optic neuritis to multiple sclerosis; decision tree in focus.
PLoS One. 2024;19:e0309702.
PubMed Abstract available

DESCHAMPS N, Nacher M, Preux PM, Takam V, et al
Pattern, causes and functional outcome of peripheral neuropathies in the Amazon region.
PLoS One. 2024;19:e0315760.
PubMed Abstract available

SHRIWASH N, Aiman A, Singh P, Basir SF, et al
Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
PLoS One. 2024;19:e0314428.
PubMed Abstract available

LEE JY, Lee SB, Yang SW, Paik JS, et al
Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
PLoS One. 2024;19:e0311093.
PubMed Abstract available

KOOSHKI A, Farmani R, Amirabadizadeh A, Mehrpour O, et al
Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
PLoS One. 2024;19:e0313851.
PubMed Abstract available

BIGDELI A, Ghaderi-Zefrehei M, Lesch BJ, Behmanesh M, et al
Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis.
PLoS One. 2024;19:e0308817.
PubMed Abstract available

January 2023

PRUMMER JK, Stein VM, Marti E, Lutterotti A, et al
Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin.
PLoS One. 2023;18:e0280864.
PubMed Abstract available

DIAS HF, Mochizuki Y, Kuhtreiber WM, Takahashi H, et al
Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
PLoS One. 2023;18:e0276423.
PubMed Abstract available

DE SONNAVILLE WFC, Steenks MH, Zuithoff NPA, Wulffraat NM, et al
Reliability and measurement error of anterior maximum voluntary bite force in children with juvenile idiopathic arthritis and healthy children.
PLoS One. 2023;18:e0280763.
PubMed Abstract available

KANSUTTIVIWAT C, Niprapan P, Tantiworawit A, Norasetthada L, et al
Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients.
PLoS One. 2023;18:e0279450.
PubMed Abstract available

VAN TIENHOVEN R, Vu AN, Kaddis JS, Roep BO, et al
Low risk for diabetic complications in type 1 diabetes patients carrying a protective insulin gene variant.
PLoS One. 2023;18:e0280872.
PubMed Abstract available

HARARI G, Gurevich M, Dolev M, Zilkha Falb R, et al
Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity study.
PLoS One. 2023;18:e0280515.
PubMed Abstract available

GON Y, Kandou T, Tsuruyama T, Iwasaki T, et al
Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model.
PLoS One. 2023;18:e0279389.
PubMed Abstract available

GRANJA DOMINGUEZ A, Romero Sevilla R, Aleman A, Duran C, et al
Study for the validation of the FeetMe(R) integrated sensor insole system compared to GAITRite(R) system to assess gait characteristics in patients with multiple sclerosis.
PLoS One. 2023;18:e0272596.
PubMed Abstract available

VICH-PEREZ P, Abanades-Herranz JC, Mora-Navarro G, Carrasco-Sayalero AM, et al
Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study.
PLoS One. 2023;18:e0281657.
PubMed Abstract available

CABANILLAS-LAZO M, Cruzalegui-Bazan C, Pascual-Guevara M, Quispe-Vicuna C, et al
Clinical and imagenologic significance of the neutrophil-to-lymphocyte ratio in neuromyelitis optica spectrum disorder: A systematic review with meta-analysis.
PLoS One. 2023;18:e0281064.
PubMed Abstract available

SOFUE T, Oguchi H, Yazawa M, Tsujita M, et al
Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
PLoS One. 2023;18:e0281945.
PubMed Abstract available

BARAK-CORREN Y, Castro VM, Javitt S, Nock MK, et al
Improving risk prediction for target subpopulations: Predicting suicidal behaviors among multiple sclerosis patients.
PLoS One. 2023;18:e0277483.
PubMed Abstract available

SWERDEL JN, Ramcharran D, Hardin J
Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.
PLoS One. 2023;18:e0281929.
PubMed Abstract available

ALAZWARI A, Johnstone A, Tafakori L, Abdollahian M, et al
Predicting the development of T1D and identifying its Key Performance Indicators in children; a case-control study in Saudi Arabia.
PLoS One. 2023;18:e0282426.
PubMed Abstract available

LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
PLoS One. 2023;18:e0281979.
PubMed Abstract available

ERSOY T, Hocaoglu E
A 3-DoF robotic platform for the rehabilitation and assessment of reaction time and balance skills of MS patients.
PLoS One. 2023;18:e0280505.
PubMed Abstract available

RAGY O, Rautemaa V, Smith A, Brenchley P, et al
Can use of the serum anti-PLA2R antibody negate the need for a renal biopsy in primary membranous nephropathy?
PLoS One. 2023;18:e0281726.
PubMed Abstract available

SOKRATOUS D, Charalambous CC, Papanicolaou EZ, Michailidou K, et al
Investigation of in-phase bilateral exercise effects on corticospinal plasticity in relapsing remitting multiple sclerosis: A registered report single-case concurrent multiple baseline design across five subjects.
PLoS One. 2023;18:e0272114.
PubMed Abstract available

MISAKI T, Naka S, Suzuki H, Lee M, et al
cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
PLoS One. 2023;18:e0282367.
PubMed Abstract available

CHOI SJ, Ahn SM, Oh JS, Hong S, et al
Serum IgG4 level during initial treatment as a predictor of relapse in IgG4-related disease.
PLoS One. 2023;18:e0282852.
PubMed Abstract available

FEHMI J, Davies AJ, Antonelou M, Keddie S, et al
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
PLoS One. 2023;18:e0281156.
PubMed Abstract available

SOHOLM U, Broadley M, Zaremba N, Divilly P, et al
Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: The Hypo-METRICS app.
PLoS One. 2023;18:e0283148.
PubMed Abstract available

LIPKA S, Ostendorf L, Schneider U, Hiepe F, et al
Increased levels of immature and activated low density granulocytes and altered degradation of neutrophil extracellular traps in granulomatosis with polyangiitis.
PLoS One. 2023;18:e0282919.
PubMed Abstract available

SEDIGHI B, Haghdoost A, Jangipour Afshar P, Abna Z, et al
Multiple sclerosis and COVID-19: A retrospective study in Iran.
PLoS One. 2023;18:e0283538.
PubMed Abstract available

LAICHINGER K, Bombach P, Dunschede J, Ruschil C, et al
No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke.
PLoS One. 2023;18:e0283476.
PubMed Abstract available

LEDEGANCK KJ, Van Eyck A, Wouters K, Vermeiren E, et al
Urinary epidermal growth factor reflects vascular health in boys with either obesity or type 1 diabetes. A role for renin, or beyond?
PLoS One. 2023;18:e0283716.
PubMed Abstract available

ZAFEIRI L, Akerfeldt T, Tolf A, Carlson K, et al
Anti-Mullerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis.
PLoS One. 2023;18:e0284288.
PubMed Abstract available

WANG Y, Hurley A, De Giorgi M, Tanner MR, et al
Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
PLoS One. 2023;18:e0283996.
PubMed Abstract available

NOPPARAT J, Khuituan P, Peerakietkhajorn S, Teanpaisan R, et al
Probiotics of Lacticaseibacillus paracasei SD1 and Lacticaseibacillus rhamnosus SD11 attenuate inflammation and beta-cell death in streptozotocin-induced type 1 diabetic mice.
PLoS One. 2023;18:e0284303.
PubMed Abstract available

HANGANU AR, Constantin A, Moise ES, Niculae CM, et al
Peripheral nervous system involvement associated with COVID-19. A systematic review of literature.
PLoS One. 2023;18:e0283827.
PubMed Abstract available

BENINI S, Pellegrini E, Descovich C, Lugaresi A, et al
Burden and resources in caregivers of people with multiple sclerosis: A qualitative study.
PLoS One. 2023;18:e0265297.
PubMed Abstract available

MARTINS ALMDS, Bernardes AB, Ferreira VA, Wanderley DC, et al
In situ assessment of Mindin as a biomarker of podocyte lesions in diabetic nephropathy.
PLoS One. 2023;18:e0284789.
PubMed Abstract available

CRAWFORD MP, Borcherding N, Karandikar NJ
IL-17 cytokines preferentially act on naive CD4+ T cells with the IL-17AF heterodimer inducing the greatest functional changes.
PLoS One. 2023;18:e0285166.
PubMed Abstract available

HAMILTON P, Blaikie K, Roberts SA, Gittins M, et al
Membranous nephropathy in the UK Biobank.
PLoS One. 2023;18:e0281795.
PubMed Abstract available

LEE SH, Lee S, Lee J, Lee JK, et al
Effective encoder-decoder neural network for segmentation of orbital tissue in computed tomography images of Graves' orbitopathy patients.
PLoS One. 2023;18:e0285488.
PubMed Abstract available

SU K, Jia Z, Wu Y, Sun Y, et al
A network causal relationship between type-1 diabetes mellitus, 25-hydroxyvitamin D level and systemic lupus erythematosus: Mendelian randomization study.
PLoS One. 2023;18:e0285915.
PubMed Abstract available

AHMAD POUZI NA, Shaharir SS, Mohd Tamil A, Mustafar R, et al
Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).
PLoS One. 2023;18:e0285461.
PubMed Abstract available

COBB J, Soliman SSM, Retuerto M, Quijano JC, et al
Changes in the gut microbiota of NOD mice in response to an oral Salmonella-based vaccine against type 1 diabetes.
PLoS One. 2023;18:e0285905.
PubMed Abstract available

HORVATH M, Herold Z, Kustel M, Tamas L, et al
Changes in the cochlear and retrocochlear parts of the auditory system in 19-39 and 40-60 years old patients with type 1 diabetes mellitus.
PLoS One. 2023;18:e0285740.
PubMed Abstract available

MACHADO-ALBA JE, Machado-Duque ME, Gaviria-Mendoza A, Duarte-Rey C, et al
Clinical characterization of a cohort of patients treated for systemic lupus erythematosus in Colombia: A retrospective study.
PLoS One. 2023;18:e0285889.
PubMed Abstract available

STAHL D, Friberg E
Formal help for persons with multiple sclerosis-Background factors associated with usage of personal assistance and home help in Sweden.
PLoS One. 2023;18:e0286010.
PubMed Abstract available

MISTRY S, Gouripeddi R, Reno CM, Abdelrahman S, et al
Detecting hypoglycemia-induced electrocardiogram changes in a rodent model of type 1 diabetes using shape-based clustering.
PLoS One. 2023;18:e0284622.
PubMed Abstract available

ZAK R, Navasardyan L, Hunak J, Martinu J, et al
PTPN22 intron polymorphism rs1310182 (c.2054-852T>C) is associated with type 1 diabetes mellitus in patients of Armenian descent.
PLoS One. 2023;18:e0286743.
PubMed Abstract available

EVEREST E, Uygunoglu U, Tutuncu M, Bulbul A, et al
Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers.
PLoS One. 2023;18:e0287463.
PubMed Abstract available

STEYN LV, Drew D, Vlachos D, Huey B, et al
Accelerated absorption of regular insulin administered via a vascularizing permeable microchamber implanted subcutaneously in diabetic Rattus norvegicus.
PLoS One. 2023;18:e0278794.
PubMed Abstract available

MEDEIROS MCS, Souza KSC, Galdino OA, Cobucci RN, et al
Impact of overweight and obesity on disease activity and remission in systemic lupus erythematosus: A systematic review and meta-analysis protocol.
PLoS One. 2023;18:e0287753.
PubMed Abstract available

ESCHWEILER M, McCrum C, Giannouli E
A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
PLoS One. 2023;18:e0286402.
PubMed Abstract available

GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
Multiple sclerosis: Exploring the limits and implications of genetic and environmental susceptibility.
PLoS One. 2023;18:e0285599.
PubMed Abstract available

TURTON JL, Brinkworth GD, Parker HM, Lim D, et al
Effects of a low-carbohydrate diet in adults with type 1 diabetes management: A single arm non-randomised clinical trial.
PLoS One. 2023;18:e0288440.
PubMed Abstract available

NAISBY J, Wilson-Menzfeld G, Baker K, Morris R, et al
Yoga and Multiple Sclerosis: Maintaining engagement in physical activity.
PLoS One. 2023;18:e0288319.
PubMed Abstract available

VIATCHENKO-KARPINSKI V, Kong L, Weng HR
Deficient AMPK activity contributes to hyperexcitability in peripheral nociceptive sensory neurons and thermal hyperalgesia in lupus mice.
PLoS One. 2023;18:e0288356.
PubMed Abstract available

VILADES E, Cordon B, Perez-Velilla J, Orduna E, et al
Evaluation of multiple sclerosis severity using a new OCT tool.
PLoS One. 2023;18:e0288581.
PubMed Abstract available

FRAGKIADAKI E, Cotterill N, Rice C, Smith JA, et al
Evaluation of the feasibility and acceptability of an integrative group psychological intervention for people with Multiple Sclerosis: A study protocol.
PLoS One. 2023;18:e0288295.
PubMed Abstract available

WANG TY, Chang FP, Yang AH, Ka SM, et al
Key pathological features characterize minimal change disease-like IgA nephropathy.
PLoS One. 2023;18:e0288384.
PubMed Abstract available

GOUGH A, Sitch A, Ferris E, Marshall T, et al
Within-subject variation of HbA1c: A systematic review and meta-analysis.
PLoS One. 2023;18:e0289085.
PubMed Abstract available

MACHADO A, Azad A, Pettersson E, Hillert J, et al
Gender differences in earnings among people with multiple sclerosis and associations with type of occupation and family composition: A population-based study with matched references.
PLoS One. 2023;18:e0288998.
PubMed Abstract available

MEIJBOOM R, York EN, Kampaite A, Harris MA, et al
Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
PLoS One. 2023;18:e0288967.
PubMed Abstract available

HERNANDEZ M, Ramon-Julvez U, Vilades E, Cordon B, et al
Explainable artificial intelligence toward usable and trustworthy computer-aided diagnosis of multiple sclerosis from Optical Coherence Tomography.
PLoS One. 2023;18:e0289495.
PubMed Abstract available

RAZIA R, Majeed F, Amin R, Mukhtar S, et al
Predictive value of alpha-synuclein expression in peripheral blood of multiple sclerosis patients: A two-dimensional assessment of a selected biomarker.
PLoS One. 2023;18:e0285022.
PubMed Abstract available

DING J, Li C, Shu K, Chen W, et al
Membrane metalloendopeptidase (MME) is positively correlated with systemic lupus erythematosus and may inhibit the occurrence of breast cancer.
PLoS One. 2023;18:e0289960.
PubMed Abstract available

HARRIS VK, Wollowitz J, Greenwald J, Carlson AL, et al
Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis.
PLoS One. 2023;18:e0290069.
PubMed Abstract available

DEFRES S, Tharmaratnam K, Michael BD, Ellul M, et al
Clinical predictors of encephalitis in UK adults-A multi-centre prospective observational cohort study.
PLoS One. 2023;18:e0282645.
PubMed Abstract available

ULLAH S, Zheng Z, Rahman W, Ullah F, et al
A computational approach to fighting type 1 diabetes by targeting 2C Coxsackie B virus protein with flavonoids.
PLoS One. 2023;18:e0290576.
PubMed Abstract available

GOOCH AM, Chowdhury SS, Zhang PM, Hu ZM, et al
Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.
PLoS One. 2023;18:e0290460.
PubMed Abstract available

TEKIN H, Frobert O, Graesli AR, Kindberg J, et al
Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
PLoS One. 2023;18:e0291063.
PubMed Abstract available

LIN DY, Andreotti AH
Structure of BTK kinase domain with the second-generation inhibitors acalabrutinib and tirabrutinib.
PLoS One. 2023;18:e0290872.
PubMed Abstract available

MONSTED MO, Holm LJ, Buschard K, Haupt-Jorgensen M, et al
Failure to replicate the diabetes alleviating effect of a maternal gluten-free diet in non-obese diabetic mice.
PLoS One. 2023;18:e0289258.
PubMed Abstract available

HOWLAND S, Huber J, Aicken C
Designing a brief and simple intervention to help young people with type 1 diabetes to live well: Protocol for developing a novel intervention with participation from young people.
PLoS One. 2023;18:e0285300.
PubMed Abstract available

SIKORSKI P, Li Y, Cheema M, Wolfe GI, et al
Serum metabolomics of treatment response in myasthenia gravis.
PLoS One. 2023;18:e0287654.
PubMed Abstract available

POLICK CS, Ploutz-Snyder R, Braley TJ, Connell CM, et al
Fatigue, pain interference, and psychiatric morbidity in multiple sclerosis: The role of childhood stress.
PLoS One. 2023;18:e0292233.
PubMed Abstract available

PHAM HN, Pham L, Sato K
Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
PLoS One. 2023;18:e0292998.
PubMed Abstract available

PARK SS, Mai M, Ploszaj M, Cai H, et al
Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
PLoS One. 2023;18:e0291948.
PubMed Abstract available

O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
PLoS One. 2023;18:e0294193.
PubMed Abstract available

KRAKENES T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, et al
The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
PLoS One. 2023;18:e0293908.
PubMed Abstract available

ABIDOV M, Sokolova K, Danilova I, Baykenova M, et al
Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently.
PLoS One. 2023;18:e0294432.
PubMed Abstract available

CHENG CW, Fang WF, Lin JD
Associations of serum keratin 1 with thyroid function and immunity in Graves' disease.
PLoS One. 2023;18:e0289345.
PubMed Abstract available

SUZUKI K, Iwata D, Namba K, Hase K, et al
Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis.
PLoS One. 2023;18:e0294745.
PubMed Abstract available

WALLE M, Arkew M, Asmerom H, Tesfaye A, et al
The diagnostic accuracy of mean platelet volume in differentiating immune thrombocytopenic purpura from hypo-productive thrombocytopenia: A systematic review and meta-analysis.
PLoS One. 2023;18:e0295011.
PubMed Abstract available

ZHOU Q, Xiong Z, Yang D, Xiong C, et al
The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
PLoS One. 2023;18:e0295135.
PubMed Abstract available

HARVENGT AA, Polle OG, Martin M, van Maanen A, et al
Post-Hypoglycemic hyperglycemia are highly relevant markers for stratification of glycemic variability and partial remission status of pediatric patients with new-onset type 1 diabetes.
PLoS One. 2023;18:e0294982.
PubMed Abstract available

TRENTIN-SONODA M, Cheff V, Gutsol A, Hebert RL, et al
Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes.
PLoS One. 2023;18:e0295284.
PubMed Abstract available

LORD SM, Bahnson HT, Greenbaum CJ, Liljenquist DR, et al
Testing a new platform to screen disease-modifying therapy in type 1 diabetes.
PLoS One. 2023;18:e0293268.
PubMed Abstract available

FALLAH M, Najafi A, Balighi K, Daneshpazhooh M, et al
Association of alternative healthy eating index and severity of pemphigus vulgaris: A cross-sectional study.
PLoS One. 2023;18:e0295026.
PubMed Abstract available

ABDULLAHI AS, Suliman A, Khan MA, Khair H, et al
Temporal trends of hemoglobin among pregnant women: The Mutaba'ah study.
PLoS One. 2023;18:e0295549.
PubMed Abstract available

WILF-YARKONI A, Feldmann K, Rubarth K, Dorsch EM, et al
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
PLoS One. 2023;18:e0288366.
PubMed Abstract available

January 2022

YU F, Zhou X, Jin X, Zhao S, et al
Rational construction of controllable autoimmune diabetes model depicting clinical features.
PLoS One. 2022;17:e0260100.
PubMed Abstract available

OKOTH K, Subramanian A, Chandan JS, Adderley NJ, et al
Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study.
PLoS One. 2022;17:e0261769.
PubMed Abstract available

ARIF B, Arif Z, Ahmad J, Perveen K, et al
Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
PLoS One. 2022;17:e0262233.
PubMed Abstract available

KALKOWSKI L, Golubczyk D, Kwiatkowska J, Domzalska M, et al
Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement.
PLoS One. 2022;17:e0262677.
PubMed Abstract available

WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
PLoS One. 2022;17:e0262480.
PubMed Abstract available

HORTON MK, McCurdy S, Shao X, Bellesis K, et al
Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
PLoS One. 2022;17:e0262093.
PubMed Abstract available

SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
PLoS One. 2022;17:e0262160.
PubMed Abstract available

HODREA J, Saeed A, Molnar A, Fintha A, et al
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
PLoS One. 2022;17:e0263285.
PubMed Abstract available

PETROVA T, Bennett K, Nanda S, Strickson S, et al
Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
PLoS One. 2022;17:e0263151.
PubMed Abstract available

LERKVALEEKUL B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, et al
Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
PLoS One. 2022;17:e0263536.
PubMed Abstract available

AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
PLoS One. 2022;17:e0263606.
PubMed Abstract available

ALAZWARI A, Abdollahian M, Tafakori L, Johnstone A, et al
Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia.
PLoS One. 2022;17:e0264118.
PubMed Abstract available

BEDI S, Richardson TM, Jia B, Saab H, et al
Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
PLoS One. 2022;17:e0261103.
PubMed Abstract available

TANIGUCHI H, Nirengi S, Ishihara K, Sakane N, et al
Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
PLoS One. 2022;17:e0263774.
PubMed Abstract available

QUIGLEY M, Earnest A, Szwarcbard N, Wischer N, et al
Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
PLoS One. 2022;17:e0263511.
PubMed Abstract available

LI JY, Sun XH, Shen DC, Yang XZ, et al
Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
PLoS One. 2022;17:e0266529.
PubMed Abstract available

MEKONNEN GA, Gelaye KA, Gebreyohannes EA, Abegaz TM, et al
Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study.
PLoS One. 2022;17:e0264626.
PubMed Abstract available

KONG X, Diao S, Xu H, Sun J, et al
Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.
PLoS One. 2022;17:e0266265.
PubMed Abstract available

MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
PLoS One. 2022;17:e0266203.
PubMed Abstract available

QEADAN F, Tingey B, Egbert J, Pezzolesi MG, et al
The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data.
PLoS One. 2022;17:e0266809.
PubMed Abstract available

MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
PLoS One. 2022;17:e0266492.
PubMed Abstract available

CHEN X, Zhang Y, Luo Z, Wu Y, et al
Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
PLoS One. 2022;17:e0264705.
PubMed Abstract available

TANA MM, Klepper A, Lyden A, Pisco AO, et al
Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
PLoS One. 2022;17:e0264307.
PubMed Abstract available

NGAMJANYAPORN P, Worawichawong S, Pisitkun P, Khiewngam K, et al
Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
PLoS One. 2022;17:e0263778.
PubMed Abstract available

CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
PLoS One. 2022;17:e0264123.
PubMed Abstract available

KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
Do Hungarian multiple sclerosis care units fulfil international criteria?
PLoS One. 2022;17:e0264328.
PubMed Abstract available

YADAV M, Ali S, Shrode RL, Shahi SK, et al
Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
PLoS One. 2022;17:e0264556.
PubMed Abstract available

BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
PLoS One. 2022;17:e0267346.
PubMed Abstract available

ROVO A, Cantoni N, Samii K, Rufer A, et al
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
PLoS One. 2022;17:e0267342.
PubMed Abstract available

FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
PLoS One. 2022;17:e0264489.
PubMed Abstract available

ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
PLoS One. 2022;17:e0264708.
PubMed Abstract available

LIN X, Liu Y, Chen Y, Huang X, et al
Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
PLoS One. 2022;17:e0265017.
PubMed Abstract available

SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
PLoS One. 2022;17:e0264557.
PubMed Abstract available

GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
PLoS One. 2022;17:e0267245.
PubMed Abstract available

RAHIM T, Levinson MA, Carufe KEW, Burak M, et al
The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.
PLoS One. 2022;17:e0267913.
PubMed Abstract available

ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
PLoS One. 2022;17:e0267504.
PubMed Abstract available

WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
PLoS One. 2022;17:e0266786.
PubMed Abstract available

HIERL KV, Krause M, Kruber D, Sterker I, et al
3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.
PLoS One. 2022;17:e0265324.
PubMed Abstract available

JIN M, Jang A, Kim WG, Kim TY, et al
Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
PLoS One. 2022;17:e0265332.
PubMed Abstract available

IIDA M, Ohtomo S, Wada NA, Ueda O, et al
TNF-alpha induces Claudin-1 expression in renal tubules in Alport mice.
PLoS One. 2022;17:e0265081.
PubMed Abstract available

BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
PLoS One. 2022;17:e0268475.
PubMed Abstract available

ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
PLoS One. 2022;17:e0268125.
PubMed Abstract available

KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
PLoS One. 2022;17:e0268783.
PubMed Abstract available

SHEU NW, Huang SH, Wu DC, Kao JY, et al
Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
PLoS One. 2022;17:e0265323.
PubMed Abstract available

COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
PLoS One. 2022;17:e0269085.
PubMed Abstract available

ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
PLoS One. 2022;17:e0268988.
PubMed Abstract available

KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
"I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
PLoS One. 2022;17:e0265861.
PubMed Abstract available

YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
PLoS One. 2022;17:e0269610.
PubMed Abstract available

ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
Optic neuritis: A South African hospital-based prospective study protocol.
PLoS One. 2022;17:e0269514.
PubMed Abstract available

HILLS SL, Soeung SC, Sarath S, Morn C, et al
An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
PLoS One. 2022;17:e0269480.
PubMed Abstract available

MAROZOFF S, Mai A, Dehghan N, Sayre EC, et al
Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.
PLoS One. 2022;17:e0270142.
PubMed Abstract available

HUANG Y, Wang WK, Zheng XM, Yang L, et al
Decreased salivary alpha-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.
PLoS One. 2022;17:e0269621.
PubMed Abstract available

PETRZALKA M, Meluzinova E, Libertinova J, Mojzisova H, et al
IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis.
PLoS One. 2022;17:e0270607.
PubMed Abstract available

ALBURNO H, Mercken L, de Vries H, Al Mohannadi D, et al
Determinants of healthful eating and physical activity among adolescents and young adults with type 1 diabetes in Qatar: A qualitative study.
PLoS One. 2022;17:e0270984.
PubMed Abstract available

RASKIN E, Achiron A, Zloto O, Neuman R, et al
Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis.
PLoS One. 2022;17:e0264918.
PubMed Abstract available

HAYASHI K, Sada KE, Asano Y, Katayama Y, et al
Real-world data on vitamin D supplementation and its impacts in systemic lupus erythematosus: Cross-sectional analysis of a lupus registry of nationwide institutions (LUNA).
PLoS One. 2022;17:e0270569.
PubMed Abstract available

KRAUSE A, Lee K, Konig D, Faist M, et al
Six weeks of whole-body vibration improves fine motor accuracy, functional mobility and quality of life in people with multiple sclerosis.
PLoS One. 2022;17:e0270698.
PubMed Abstract available

AFYOUNI H, Haris B, Syed N, Ahmed I, et al
Sib-pair subgroup familial type 1 diabetes mellitus in children in the state of Qatar.
PLoS One. 2022;17:e0271182.
PubMed Abstract available

AHN SS, Yoon T, Song JJ, Park YB, et al
Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study.
PLoS One. 2022;17:e0271055.
PubMed Abstract available

ZANOTTO T, Rice LA, Sosnoff JJ
Frailty among people with multiple sclerosis who are wheelchair users.
PLoS One. 2022;17:e0271688.
PubMed Abstract available

SHAH R, Mohammed YN, Koehler TJ, Kaur J, et al
Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study.
PLoS One. 2022;17:e0269466.
PubMed Abstract available

BREW-SAM N, Desborough J, Parkinson A, Murugappan K, et al
A user preference analysis of commercial breath ketone sensors to inform the development of portable breath ketone sensors for diabetes management in young people.
PLoS One. 2022;17:e0269925.
PubMed Abstract available

LOPEZ ORTEGA JM, Martinez PS, Acevedo-Leon D, Capell NE, et al
Anti-TSH receptor antibodies (TRAb): Comparison of two third generation automated immunoassays broadly used in clinical laboratories and results interpretation.
PLoS One. 2022;17:e0270890.
PubMed Abstract available

VITTURI BK, Rahmani A, Dini G, Montecucco A, et al
Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.
PLoS One. 2022;17:e0272156.
PubMed Abstract available

UELAND GA, Ernes T, Vonheim Madsen T, Husebye ES, et al
Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.
PLoS One. 2022;17:e0272133.
PubMed Abstract available

TU H, Li N, Liu W, Fan Z, et al
Effects of transcutaneous tibial nerve stimulation on females with overactive bladder syndrome in multiple sclerosis a protocol for a systematic review and meta-analysis.
PLoS One. 2022;17:e0269371.
PubMed Abstract available

PAPADIMITRIOU E, Boutzios G, Mathioudakis AG, Vlahos NF, et al
Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis.
PLoS One. 2022;17:e0260759.
PubMed Abstract available

QIU LNY, Cai SV, Chan D, Hess RS, et al
Seasonality and geography of diabetes mellitus in United States of America dogs.
PLoS One. 2022;17:e0272297.
PubMed Abstract available

MAHMOUD RH, Fouad NA, Hefzy EM, Shaker OG, et al
The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus.
PLoS One. 2022;17:e0268176.
PubMed Abstract available

MORRISON AE, Chong K, Senior PA, Lam A, et al
A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes.
PLoS One. 2022;17:e0271096.
PubMed Abstract available

HOHN A, McGurnaghan SJ, Caparrotta TM, Jeyam A, et al
Large socioeconomic gap in period life expectancy and life years spent with complications of diabetes in the Scottish population with type 1 diabetes, 2013-2018.
PLoS One. 2022;17:e0271110.
PubMed Abstract available

CRABTREE E, Uribe K, Smith SM, Roberts D, et al
Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.
PLoS One. 2022;17:e0270972.
PubMed Abstract available

LI Y, Yu X, Zhang W, Lv J, et al
Epidemiological characteristics and pathological changes of primary glomerular diseases.
PLoS One. 2022;17:e0272237.
PubMed Abstract available

CHOI YJ, Kim C, Choi EW, Lee SH, et al
MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
PLoS One. 2022;17:e0270416.
PubMed Abstract available

SEKIGUCHI K, Ishizuchi K, Takizawa T, Motegi H, et al
Anemia in female patients with myasthenia gravis.
PLoS One. 2022;17:e0273720.
PubMed Abstract available

STORRAR J, Chinnadurai R, Sinha S, Kalra PA, et al
The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience.
PLoS One. 2022;17:e0268421.
PubMed Abstract available

VIROONLUECHA P, Egea-Lopez E, Santa J
Evaluation of blood glucose level control in type 1 diabetic patients using deep reinforcement learning.
PLoS One. 2022;17:e0274608.
PubMed Abstract available

TAKASHI Y, Maeda Y, Toyokawa K, Oda N, et al
Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes.
PLoS One. 2022;17:e0274182.
PubMed Abstract available

JOH K, Nakazato T, Hashiguchi A, Shimizu A, et al
Structural modeling for Oxford histological classifications of immunoglobulin A nephropathy.
PLoS One. 2022;17:e0268731.
PubMed Abstract available

LAROCQUE JC, Gardy S, Sammut M, McBey DP, et al
Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus.
PLoS One. 2022;17:e0273701.
PubMed Abstract available

YOSHIKAWA H, Adachi Y, Nakamura Y, Kuriyama N, et al
Two-step nationwide epidemiological survey of myasthenia gravis in Japan 2018.
PLoS One. 2022;17:e0274161.
PubMed Abstract available

CARREIRA M, Ruiz de Adana MS, Pinzon JL, Anarte-Ortiz MT, et al
Internet-based Cognitive-behavioral therapy (CBT) for depressive symptomatology in individuals with type 1 diabetes (WEB_TDDI1 study): A randomized controlled trial protocol.
PLoS One. 2022;17:e0274551.
PubMed Abstract available

KUENDIG S, Kool J, Polhemus A, Schallert W, et al
Three weeks of rehabilitation improves walking capacity but not daily physical activity in patients with multiple sclerosis with moderate to severe walking disability.
PLoS One. 2022;17:e0274348.
PubMed Abstract available

SMAOUI MR, Lafi A
Leeno: Type 1 diabetes management training environment using smart algorithms.
PLoS One. 2022;17:e0274534.
PubMed Abstract available

NING L, Wang B
Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis.
PLoS One. 2022;17:e0274565.
PubMed Abstract available

ABUAF AF, Bunting SR, Klein S, Carroll T, et al
Analysis of the extent of limbic system changes in multiple sclerosis using FreeSurfer and voxel-based morphometry approaches.
PLoS One. 2022;17:e0274778.
PubMed Abstract available

ALMAZROUEI R, Sharma C, Afandi B, Aldahmani KM, et al
Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes.
PLoS One. 2022;17:e0264545.
PubMed Abstract available

DING MY, Li B, Yang M, Zhai WS, et al
Effectiveness of shengxuexiaoban capsules combined with glucocorticoid therapy for immune thrombocytopenia: A meta-analysis.
PLoS One. 2022;17:e0275122.
PubMed Abstract available

YAMAGUCHI M, Ito M, Sugiyama H, Iwagaitsu S, et al
Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan.
PLoS One. 2022;17:e0274483.
PubMed Abstract available

GUIMARAES JAR, Furtado SDC, Lucas ACDS, Mori B, et al
Diagnostic test accuracy of novel biomarkers for lupus nephritis-An overview of systematic reviews.
PLoS One. 2022;17:e0275016.
PubMed Abstract available

JENSEN MH, Cichosz SL, Gustenhoff P, Nikontovic A, et al
Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
PLoS One. 2022;17:e0274626.
PubMed Abstract available

STORRAR J, Gill-Taylor T, Chinnadurai R, Chrysochou C, et al
A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades.
PLoS One. 2022;17:e0276053.
PubMed Abstract available

MASIS L, Kanya L, Kiogora J, Kiapi L, et al
Estimating treatment costs for uncomplicated diabetes at a hospital serving refugees in Kenya.
PLoS One. 2022;17:e0276702.
PubMed Abstract available

SELVARAJ MS, Paruchuri K, Haidermota S, Bernardo R, et al
Genome-wide discovery for diabetes-dependent triglycerides-associated loci.
PLoS One. 2022;17:e0275934.
PubMed Abstract available

GRANLUND L, Hedin A, Korsgren O, Skog O, et al
Altered microvasculature in pancreatic islets from subjects with type 1 diabetes.
PLoS One. 2022;17:e0276942.
PubMed Abstract available

AMATYA M, Pant AD
Clinical and histopathological study of renal biopsy in Nepalese children: A single center experience.
PLoS One. 2022;17:e0276172.
PubMed Abstract available

DAVID BL, Ivan GJ, Emilio PE, Daniela MJ, et al
Low serum uromodulin levels and their association with lupus flares.
PLoS One. 2022;17:e0276481.
PubMed Abstract available

CHEN W, Yu Y, Liu Y, Song C, et al
Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats.
PLoS One. 2022;17:e0277061.
PubMed Abstract available

RICCI S, Perugia F, Piccini B, Lodi L, et al
DR4/DQ2 haplotype confers susceptibility to T1DM with early clinical disease onset: A retrospective analysis in a tertiary-care hospital in Italy.
PLoS One. 2022;17:e0276896.
PubMed Abstract available

BAYARMUNKH O, Ganbold C, Das S, Davaatseren U, et al
Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
PLoS One. 2022;17:e0277055.
PubMed Abstract available

BOYARCHUK O, Dobrovolska L, Svystunovych H
Selective immunoglobulin A deficiency in children with diabetes mellitus: Data from a medical center in Ukraine.
PLoS One. 2022;17:e0277273.
PubMed Abstract available

YANG B, Parker RB, Meibohm B, Temrikar ZH, et al
Alcohol inhibits the metabolism of dimethyl fumarate to the active metabolite responsible for decreasing relapse frequency in the treatment of multiple sclerosis.
PLoS One. 2022;17:e0278111.
PubMed Abstract available

VALORI M, Lehikoinen J, Jansson L, Clancy J, et al
High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls.
PLoS One. 2022;17:e0278245.
PubMed Abstract available

CROMER SJ, Chen V, Han C, Marshall W, et al
Algorithmic identification of atypical diabetes in electronic health record (EHR) systems.
PLoS One. 2022;17:e0278759.
PubMed Abstract available

ALAZMI A, Viktor S, Erjavec M
Exploring the determinants of mental health, wellbeing, and lifestyle in 8-11 year old children with type 1 diabetes and their healthy counterparts in Kuwait.
PLoS One. 2022;17:e0272948.
PubMed Abstract available

CLARKSON TC, Iguchi N, Xie AX, Malykhina AP, et al
Differential transcriptomic changes in the central nervous system and urinary bladders of mice infected with a coronavirus.
PLoS One. 2022;17:e0278918.
PubMed Abstract available

BROOME CM, Hooda N, Su J, Jiang X, et al
Medically-attended anxiety and depression is increased among newly diagnosed patients with cold agglutinin disease: Analysis of an integrated claim-clinical cohort in the United States.
PLoS One. 2022;17:e0276617.
PubMed Abstract available

AL-KAFAJI G, Alwehaidah MS, Alsabbagh MM, Alharbi MA, et al
Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple sclerosis.
PLoS One. 2022;17:e0279237.
PubMed Abstract available

PARK HY, Chae MK, Ko J, Kikkawa DO, et al
Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
PLoS One. 2022;17:e0279060.
PubMed Abstract available

WOCHATZ M, Schraplau A, Engel T, Zecher MM, et al
Application of eccentric training in various clinical populations: Protocol for a multi-centered pilot and feasibility study in people with low back pain and people with multiple sclerosis.
PLoS One. 2022;17:e0270875.
PubMed Abstract available

BEECHAM AH, Amezcua L, Chinea A, Manrique CP, et al
Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.
PLoS One. 2022;17:e0279132.
PubMed Abstract available

LANDRUM KR, Pence BW, Gaynes BN, Dussault JM, et al
The cross-sectional association of stressful life events with depression severity among patients with hypertension and diabetes in Malawi.
PLoS One. 2022;17:e0279619.
PubMed Abstract available

January 2021

JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
PLoS One. 2021;16:e0243150.
PubMed Abstract available

KATEWA A, Suto E, Hui J, Heredia J, et al
The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
PLoS One. 2021;16:e0244439.
PubMed Abstract available

WILLETT K, Khan RS, Dine K, Wessel H, et al
Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
PLoS One. 2021;16:e0243862.
PubMed Abstract available

CHA HJ, Hwang J, Lee LE, Park Y, et al
The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
PLoS One. 2021;16:e0244950.
PubMed Abstract available

KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
PLoS One. 2021;16:e0244766.
PubMed Abstract available

ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
PLoS One. 2021;16:e0245721.
PubMed Abstract available

SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
PLoS One. 2021;16:e0245978.
PubMed Abstract available

HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
PLoS One. 2021;16:e0245869.
PubMed Abstract available

THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
PLoS One. 2021;16:e0245844.
PubMed Abstract available

LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
PLoS One. 2021;16:e0245826.
PubMed Abstract available

BSTEH G, Assar H, Hegen H, Heschl B, et al
COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
PLoS One. 2021;16:e0255316.
PubMed Abstract available

AVARI P, Unsworth R, Rilstone S, Uduku C, et al
Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
PLoS One. 2021;16:e0254951.
PubMed Abstract available

GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
The nature of genetic and environmental susceptibility to multiple sclerosis.
PLoS One. 2021;16:e0246157.
PubMed Abstract available

WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
PLoS One. 2021;16:e0247173.
PubMed Abstract available

SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
PLoS One. 2021;16:e0256379.
PubMed Abstract available

HE J, Kong D, Yang Z, Guo R, et al
Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
PLoS One. 2021;16:e0247662.
PubMed Abstract available

PAMPHLETT R, Doble PA, Bishop DP
Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
PLoS One. 2021;16:e0246748.
PubMed Abstract available

HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
PLoS One. 2021;16:e0248937.
PubMed Abstract available

GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
PLoS One. 2021;16:e0247813.
PubMed Abstract available

GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
PLoS One. 2021;16:e0248965.
PubMed Abstract available

WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
PLoS One. 2021;16:e0247501.
PubMed Abstract available

KIM SE, Kim J, Lee JY, Lee SB, et al
Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
PLoS One. 2021;16:e0249988.
PubMed Abstract available

DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
PLoS One. 2021;16:e0249611.
PubMed Abstract available

MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
PLoS One. 2021;16:e0249592.
PubMed Abstract available

PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
PLoS One. 2021;16:e0249460.
PubMed Abstract available

ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
PLoS One. 2021;16:e0247052.
PubMed Abstract available

CHOI S, Spini M, Hua J, Harrison DM, et al
Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
PLoS One. 2021;16:e0249973.
PubMed Abstract available

LUU T, Cheung JF, Baccon J, Waldner H, et al
Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
PLoS One. 2021;16:e0250340.
PubMed Abstract available

SAKUNRANGSIT N, Metheepakornchai P, Kumpunya S, Greenblatt MB, et al
Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model.
PLoS One. 2021;16:e0250215.
PubMed Abstract available

LIU GY, Wu Y, Kong FY, Ma S, et al
BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.
PLoS One. 2021;16:e0243014.
PubMed Abstract available

SATITPITAKUL V, Rattanaphong T, Pruksakorn V
Meibomian glands dropout in patients with inactive thyroid related orbitopathy.
PLoS One. 2021;16:e0250617.
PubMed Abstract available

STERNBACH S, West N, Singhal NK, Clements R, et al
The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
PLoS One. 2021;16:e0250486.
PubMed Abstract available

GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
PLoS One. 2021;16:e0250647.
PubMed Abstract available

ALKHATEEB H, El Fathi A, Ghanbari M, Haidar A, et al
Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
PLoS One. 2021;16:e0248280.
PubMed Abstract available

SENDIC S, Mansouri L, Lundberg S, Nopp A, et al
B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
PLoS One. 2021;16:e0248056.
PubMed Abstract available

SHAHARIR SS, Chua SH, Mohd R, Mustafar R, et al
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
PLoS One. 2021;16:e0248845.
PubMed Abstract available

CANDADAI AA, Liu F, Fouda AY, Alfarhan M, et al
Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis.
PLoS One. 2021;16:e0247901.
PubMed Abstract available

IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
PLoS One. 2021;16:e0248549.
PubMed Abstract available

WILSKI M, Brola W, Luniewska M, Tomczak M, et al
The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
PLoS One. 2021;16:e0248135.
PubMed Abstract available

SATO H, Ichikawa D, Okada E, Suzuki T, et al
Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
PLoS One. 2021;16:e0251294.
PubMed Abstract available

LU Z, Liu W, Gao H, Chen W, et al
Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
PLoS One. 2021;16:e0251131.
PubMed Abstract available

FATOYE F, Gebrye T, Svenson LW
Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
PLoS One. 2021;16:e0251409.
PubMed Abstract available

LIAO K, Chen K, Brett S, Gehman A, et al
Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
PLoS One. 2021;16:e0249049.
PubMed Abstract available

CHARNIGA K, Cucunuba ZM, Walteros DM, Mercado M, et al
Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017.
PLoS One. 2021;16:e0252236.
PubMed Abstract available

KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
PLoS One. 2021;16:e0251338.
PubMed Abstract available

CARTER B, Hayes C, Smith A, Pennington A, et al
A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
PLoS One. 2021;16:e0251484.
PubMed Abstract available

STOUGAARD EB, Winther SA, Amadid H, Frimodt-Moller M, et al
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
PLoS One. 2021;16:e0254859.
PubMed Abstract available

MECA-LALLANA JE, Maurino J, Perez-Miralles F, Forero L, et al
Quantifying the patient s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
PLoS One. 2021;16:e0255317.
PubMed Abstract available

NEGASH Z, Berha AB, Shibeshi W, Ahmed A, et al
Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
PLoS One. 2021;16:e0251709.
PubMed Abstract available

HOFFMAN WH, Whelan SA, Lee N
Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
PLoS One. 2021;16:e0254116.
PubMed Abstract available

SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
PLoS One. 2021;16:e0257809.
PubMed Abstract available

SWANN JW, Tayler S, Hall H, Sparrow R, et al
Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
PLoS One. 2021;16:e0257700.
PubMed Abstract available

MCCALL JL, Blair HC, Blethen KE, Hall C, et al
Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.
PLoS One. 2021;16:e0249442.
PubMed Abstract available

GAJ S, Ontaneda D, Nakamura K
Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
PLoS One. 2021;16:e0255939.
PubMed Abstract available

KIRILMAZ OB, Salegaonkar AR, Shiau J, Uzun G, et al
Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
PLoS One. 2021;16:e0254718.
PubMed Abstract available

AHN SS, Yoon T, Song JJ, Park YB, et al
Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
PLoS One. 2021;16:e0254226.
PubMed Abstract available

JOHNSON M, Ehlers S, Fernell E, Hajjari P, et al
Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review.
PLoS One. 2021;16:e0253844.
PubMed Abstract available

BRATT G, Brannstrom J, Missalidis C, Nystrom T, et al
Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
PLoS One. 2021;16:e0254079.
PubMed Abstract available

NGUYEN THP, Fagerland MW, Deyab G, Hjeltnes G, et al
Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
PLoS One. 2021;16:e0253793.
PubMed Abstract available

FAGBAMIGBE AF, Norrman E, Bergh C, Wennerholm UB, et al
Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.
PLoS One. 2021;16:e0253389.
PubMed Abstract available

VAN DOORN WPTM, Foreman YD, Schaper NC, Savelberg HHCM, et al
Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
PLoS One. 2021;16:e0253125.
PubMed Abstract available

VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
PLoS One. 2021;16:e0253419.
PubMed Abstract available

ROGACZEWSKA M, Michalak S, Stopa M
Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
PLoS One. 2021;16:e0253417.
PubMed Abstract available

WYSOCKA-MINCEWICZ M, Golebiewska J, Baszynska-Wilk M, Olechowski A, et al
Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes.
PLoS One. 2021;16:e0252588.
PubMed Abstract available

WORAWICHAWONG S, Plumworasawat S, Liwlompaisan W, Sumethkul V, et al
Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy.
PLoS One. 2021;16:e0252638.
PubMed Abstract available

PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
PLoS One. 2021;16:e0250820.
PubMed Abstract available

ROZYCKA J
How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
PLoS One. 2021;16:e0258740.
PubMed Abstract available

PARIKH RV, Tan TC, Fan D, Law D, et al
Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
PLoS One. 2021;16:e0257674.
PubMed Abstract available

MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
PLoS One. 2021;16:e0258017.
PubMed Abstract available

NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
PLoS One. 2021;16:e0256845.
PubMed Abstract available

SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
Multiple sclerosis reduces synchrony of the magnocellular pathway.
PLoS One. 2021;16:e0255324.
PubMed Abstract available

JANG SY, Choi SH, Kikkawa D, Lee EJ, et al
Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
PLoS One. 2021;16:e0255344.
PubMed Abstract available

GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
Genetic susceptibility to multiple sclerosis in African Americans.
PLoS One. 2021;16:e0254945.
PubMed Abstract available

SIDDIG O, Mustafa MB, Kordofani Y, Gibson J, et al
The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
PLoS One. 2021;16:e0254634.
PubMed Abstract available

MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
PLoS One. 2021;16:e0258437.
PubMed Abstract available

TEZUKA Y, Eguchi-Ishimae M, Ozaki E, Ito T, et al
Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
PLoS One. 2021;16:e0258090.
PubMed Abstract available

LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
PLoS One. 2021;16:e0253337.
PubMed Abstract available

MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
PLoS One. 2021;16:e0259114.
PubMed Abstract available

KIM SS, Hudgins AD, Yang J, Zhu Y, et al
A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
PLoS One. 2021;16:e0257265.
PubMed Abstract available

OSAKI T, Souri M, Ichinose A
Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
PLoS One. 2021;16:e0257322.
PubMed Abstract available

AHMAD I, Wergeland S, Oveland E, Bo L, et al
A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
PLoS One. 2021;16:e0256155.
PubMed Abstract available

NATHAN DM, Krause-Steinrauf H, Braffett BH, Arends VL, et al
Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.
PLoS One. 2021;16:e0257154.
PubMed Abstract available

KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
PLoS One. 2021;16:e0259855.
PubMed Abstract available

ALKETBI A, Basit S, Hamza N, Walton LM, et al
The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
PLoS One. 2021;16:e0258752.
PubMed Abstract available

PARUNYAKUL K, Srisuksai K, Charoenlappanit S, Phaonakrop N, et al
Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
PLoS One. 2021;16:e0256140.
PubMed Abstract available

SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
PLoS One. 2021;16:e0261050.
PubMed Abstract available

VALORI M, Jansson L, Tienari PJ
CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
PLoS One. 2021;16:e0261002.
PubMed Abstract available

ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
Bacterial variation in the oral microbiota in multiple sclerosis patients.
PLoS One. 2021;16:e0260384.
PubMed Abstract available

RENAUD A, Caristan A, Seguin A, Agard C, et al
Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.
PLoS One. 2021;16:e0260196.
PubMed Abstract available

BOCH K, Drager S, Zillikens D, Hudemann C, et al
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
PLoS One. 2021;16:e0259586.
PubMed Abstract available

HSU CY, Chueh YS, Kuo ML, Lee PT, et al
Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
PLoS One. 2021;16:e0261727.
PubMed Abstract available

BLUTHGEN C, Patella M, Euler A, Baessler B, et al
Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis.
PLoS One. 2021;16:e0261401.
PubMed Abstract available

COOLEN M, Broadley M, Hendrieckx C, Chatwin H, et al
The impact of hypoglycemia on quality of life and related outcomes in children and adolescents with type 1 diabetes: A systematic review.
PLoS One. 2021;16:e0260896.
PubMed Abstract available

MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
PLoS One. 2021;16:e0261097.
PubMed Abstract available

MANUWALD U, Schoffer O, Kugler J, Riemenschneider H, et al
Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany.
PLoS One. 2021;16:e0262171.
PubMed Abstract available

CAREY IM, Banchoff E, Nirmalananthan N, Harris T, et al
Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
PLoS One. 2021;16:e0261983.
PubMed Abstract available

MIDTHASSEL TC, Hansen AH
Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.
PLoS One. 2021;16:e0261471.
PubMed Abstract available

CH'NG JH, Moll K, Wyss K, Hammar U, et al
Enhanced virulence of Plasmodium falciparum in blood of diabetic patients.
PLoS One. 2021;16:e0249666.
PubMed Abstract available

GAUDILLIERE M, Marsot C, Balaire L, Groisne L, et al
Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes.
PLoS One. 2021;16:e0251693.
PubMed Abstract available

LO CH, Wang YH, Tsai CF, Chan KC, et al
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
PLoS One. 2021;16:e0251918.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.